Stojsic, Vladimir, et al. “Real World Data Survival Outcomes of First Line Immunotherapy With Pembrolizumab in High Expressers With Stage IV Non-Small Cell Lung Cancer”. Radiology and Oncology, vol. 60, no. 3, Sept. 2026, pp. 450-8, https://radioloncol.com/index.php/ro/article/view/4876.